For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

Study Finds Rapamycin Enhances Brain Blood Flow in Alzheimer’s Risk Group

Oct 4, 2026
Study Finds Rapamycin Enhances Brain Blood Flow in Alzheimer’s Risk Group

A new study offers hope for individuals at significantly higher risk of developing Alzheimer’s disease later in life. Ai-Ling Lin, a professor in the School of Medicine and an investigator at the Roy Blunt NextGen Precision Health building, is working to identify ways to prevent the onset of the disease. Her research focuses on people who carry the APOE4 gene variant, which is associated with a higher risk of Alzheimer’s disease. These individuals often experience reduced blood flow to certain regions of the brain years before memory problems emerge, making diminished cerebral blood flow a potential early indicator of Alzheimer’s risk.

In her latest study, Lin found that an anti-aging drug, rapamycin, increased blood flow to the brains of healthy middle-aged adults who carry the APOE4 gene. "Alzheimer’s tends to happen more in older people, especially for those with APOE4," Lin explains. "If we can slow down aging in the brain for those people most at risk, maybe we can reduce the risk of them developing Alzheimer’s disease."

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

Before joining the University of Missouri, Lin studied rapamycin, a drug typically prescribed to prevent organ transplant rejection and to treat certain rare diseases. Her previous research indicated that rapamycin could also slow down brain aging and improve brain blood flow in mice with the APOE4 variant.

For the recent study, Lin aimed to determine whether the same benefits would extend to people aged 45 to 65 who carry the APOE4 gene but have not yet developed symptoms of Alzheimer’s disease. Participants with and without the gene variant took a low dose of rapamycin daily for four weeks. The results showed that only those with the APOE4 variant experienced improved blood flow in the brain, suggesting that the drug could help preserve cognitive function for those at higher risk of developing Alzheimer’s disease.

Notably, the study found that females with APOE4 saw the greatest improvement in brain blood flow, which is significant given that nearly two-thirds of people with Alzheimer’s are women. Lin emphasizes that this research exemplifies precision medicine, as it seeks to identify who can benefit most from this drug. The study appears in the Journal of Cerebral Blood Flow & Metabolism, highlighting the potential for targeted interventions in Alzheimer's prevention.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)